Princeton Global Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,600
| Closed | -$24K | – | 610 |
|
|
2022
Q1 | $24K | Hold |
1,600
| – | – | 0.01% | 343 |
|
|
2021
Q4 | $28K | Hold |
1,600
| – | – | 0.01% | 307 |
|
|
2021
Q3 | $34K | Hold |
1,600
| – | – | 0.01% | 288 |
|
|
2021
Q2 | $32K | Hold |
1,600
| – | – | 0.01% | 297 |
|
|
2021
Q1 | $47K | Hold |
1,600
| – | – | 0.02% | 247 |
|
|
2020
Q4 | $48K | Buy |
+1,600
| New | +$48K | 0.02% | 246 |
|